Search Results - "DeStefano, Christin B."

Management of post‐transplant lymphoproliferative disorders by DeStefano, Christin B., Desai, Sanjal H., Shenoy, Aarthi G., Catlett, Joseph P.

“…Summary The post‐transplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that are one of the most serious complications of bone…”
Get full text

Incident Rate Limitations in Retrospective Observational Military Cancer Research by Sayers, David R, DeStefano, Christin B

“…ABSTRACT The unique jobs, exposures, and deployments in the military generate questions regarding cancer risks; however, incidence rates alone from…”
Get full text

The Evolving AML Genomic Landscape: Therapeutic Implications by Horibata, Sachi, Alyateem, George, DeStefano, Christin B, Gottesman, Michael M

“…Improved understanding of the genomic and molecular landscape of acute myeloid leukemia (AML) has resulted in a significant evolution of our understanding of…”
Get more information

Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia by Goswami, Meghali, Gui, Gege, Dillon, Laura W, Lindblad, Katherine E, Thompson, Julie, Valdez, Janet, Kim, Dong-Yun, Ghannam, Jack Y, Oetjen, Karolyn A, Destefano, Christin B, Smith, Dana M, Tekleab, Hanna, Li, Yeusheng, Dagur, Pradeep, Hughes, Thomas, Marté, Jennifer L, del Rivero, Jaydira, Klubo-Gwiezdzinksa, Joanna, Gulley, James L, Calvo, Katherine R, Lai, Catherine, Hourigan, Christopher S

“…BackgroundThe powerful ‘graft versus leukemia’ effect thought partly responsible for the therapeutic effect of allogeneic hematopoietic cell transplantation in…”
Get full text

Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response by Wong, Hong Yuen, Sung, Anthony D, Lindblad, Katherine E, Sheela, Sheenu, Roloff, Gregory W, Rizzieri, David, Goswami, Meghali, Mulé, Matthew P, Ramos, Nestor R, Tang, Jingrong, Thompson, Julie, DeStefano, Christin B, Romero, Kristi, Dillon, Laura W, Kim, Dong-Yun, Lai, Catherine, Hourigan, Christopher S

“…Measurable residual disease (MRD) testing after initial chemotherapy treatment can predict relapse and survival in acute myeloid leukemia (AML). However, it…”
Get full text

Real‐world outcomes of post‐transplant lymphoproliferative disorder treated with risk‐stratified sequential therapy by DeStefano, Christin B.

Get full text

Second Chances by DeStefano, Christin B

Get full text

Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia by Popescu, Bogdan, Sheela, Sheenu, Thompson, Julie, Grasmeder, Sophia, Intrater, Therese, DeStefano, Christin B., Hourigan, Christopher S., Lai, Catherine

“…Therapy for those with relapsed or refractory acute myeloid leukemia is suboptimal. Studies have suggested that timed sequential salvage combination cytotoxic…”
Get full text

Heterogeneity in refractory acute myeloid leukemia by Horibata, Sachi, Gui, Gege, Lack, Justin, DeStefano, Christin B., Gottesman, Michael M., Hourigan, Christopher S.

“…Successful clinical remission to therapy for acute myeloid leukemia (AML) is required for long-term survival to be achieved. Despite trends in improved…”
Get full text

Are veterans at increased risk of myeloproliferative neoplasms? by DeStefano, Christin B., Burwick, Nicholas, Helmer, Drew A.

Get full text

The impact of environmental ultraviolet exposure on the clinical course of mycosis fungoides by DeStefano, Christin B., Desale, Sameer, Fernandez, Stephen J., Shenoy, Aarthi G.

“…As phototherapy plays an important role in the treatment of early-stage mycosis fungoides (MF), it is possible that environmental ultraviolet (UV) exposure…”
Get full text

Insane in the membrane: A case of hereditary spherocytic pyropoikilocytosis by Gibson, Steven J., Kalfa, Theodosia A., DeStefano, Christin B.

Get full text

Survival of U.S. Military Service Members With Lymphoma by Ancira, Gilbert, Romain, Joshua, Pham, Kevin, Thornton, Jennifer A, DeStefano, Christin B

“…ABSTRACT Introduction Cancer is a prominent cause of mortality in today’s active duty service members (ADSMs), killing over 700 ADSMs between 2004 and 2015…”
Get full text

Prognostic impact of second primary malignancies in multiple myeloma: An ASCO CancerLinQ discovery analysis of the modern era by Gibson, Steven J., Cooper, John D., Pham, Kevin, Sunderland, Kevin, Thornton, Jennifer A., DeStefano, Christin B.

Get full text

Real‐world Big‐data: Strengths and weaknesses of ASCO's CancerLinQ® discovery multiple myeloma dataset by DeStefano, Christin B., Thornton, Jennifer A., Gibson, Steven J., Pham, Kevin, Miller, Robert S., Sunderland, Kevin

Get full text

The emerging importance and evolving understanding of clonal hematopoiesis in multiple myeloma by DeStefano, Christin B., Gibson, Steven J., Sperling, Adam S., Richardson, Paul G., Ghobrial, Irene, Mo, Clifton C.

“…Multiple myeloma (MM) is the second most common hematologic malignancy diagnosed in the United States. With a growing arsenal of novel therapies, patients are…”
Get full text

Incidence of cancer among U.S. combat casualties: a DoD Trauma Registry study by DeStefano, Christin B., Shaw, Krista, Gundlapalli, Adi V., Chung, Kevin K., Poltavskiy, Eduard, Stewart, Ian J.

Get full text

CAR T-Cell Therapy for Patients with Multiple Myeloma: Current Evidence and Challenges by Rendo, Matthew J, Joseph, Jacinth J, Phan, Liem Minh, DeStefano, Christin B

“…The therapeutic landscape of multiple myeloma (MM) has benefited from an emergence of novel therapies over the last decade. By inducing T-cell kill of target…”
Get full text

Real-World Pitfalls of Analyzing Real-World Data: A Cautionary Note and Path Forward by Cooper, John D, Shou, Karen, Sunderland, Kevin, Pham, Kevin, Thornton, Jennifer A, DeStefano, Christin B

“…Real-world data (RWD) are pervasive in oncology research and offer insights into clinical trends and patient outcomes. However, RWD have shortcomings, making…”
Get more information

DA‐EPOCH‐R for post‐transplant lymphoproliferative disorders by DeStefano, Christin B., Malkovska, Vera, Rafei, Hind, Shenoy, Aarthi, Fitzpatrick, Kelly, Aggarwal, Anita, Catlett, Joseph P.

“…Background Post‐transplant lymphoproliferative disorders (PTLD) are a potentially fatal group of neoplasms arising in an immunodeficient environment. Although…”
Get full text